TABLE 1.
Microarray analysis of differentially expressed miRNAs in PHHs treated with CDCA (25 μM), GW4064 (1 μM), or FGF19 (40 ng/ml)
| MicroRNA Expression (log 2 ratio) | |||
|---|---|---|---|
| Annotation | CDCA | GW4064 | FGF19 |
| miR-637 | 0.60 | 0.10 | 0.10 |
| miR-422a | 0.16 | 0.51 | 0.63 |
| miR-622 | 0.55 | 0.75 | 0.72 |
| miR-487b | −0.9 | −0.76 | −0.41 |
| miR-597 | −0.65 | −0.57 | −0.44 |
| miR-122a | 0.14 | 0.39 | 0.31 |
* Log2 (treated sample/control) ratios: >50% differential expression in one or more treatment samples, P < 0.05, n = 3. The most abundant miR-122a in human hepatocytes is also included.